Thrombolytic Treatment for Myocardial Infarction: Highlighting Healthcare Affordability and Drug Market Segmentation in India

posted Nov 25, 2016, 1:48 AM by Unknown user   [ updated Nov 30, 2016, 2:01 AM ]


This study looks at the available life-saving treatments for heart attacks and ischaemic heart diseases administered in India, focusing on streptokinase and finding that it is the life-saving clot-buster for the majority of patients. This brings to light that the surgical intervention of angioplasty is more of an income-biased treatment. Public-funded research and development of indigenous streptokinase has directly enabled access to treatment, especially for economically challenged patients. Read more at: